Autem Therapeutics

Developer of bioelectric technology-based device for cancer

placeHanover, New Hampshire, United States calendar_todayFounded 2022 groups10 employees language autemtherapeutics.com

Registered entities

Investor mix

3 investors on record; lead investors include Zentynel.

Investor typeCountShare
Venture capital133%
Private equity267%
Coming soon